Methotrexate, Vinblastine, Doxorubicin and Cisplatin (MVAC) Followed by Gemcitabine Plus Cisplatin (GEM+CDDP) in Locally Advanced or Metastatic Bladder Cancer

NCT00635726 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

41

Enrollment

OTHER

Sponsor class

Stopped Due to poor accrual

Conditions

Bladder Cancer

Interventions

DRUG: Methotrexate
DRUG: Vinblastine
DRUG: Doxorubicin
DRUG: Cisplatin
DRUG: Cisplatin
DRUG: Gemcitabine

Sponsor

Hellenic Oncology Research Group

Collaborators

[object Object]